Home NDC 0363-0252 Menstrual Relief
Product NDC 0363-0252
11-digit product format 003630252
Labeler code 0363
Product ID 0363-0252_d94a98f6-b7da-4a92-99aa-4c7f5db6c64d
Type HUMAN OTC DRUG
Nonproprietary name Acetaminophen, Caffeine and Pyrilamine maleate
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Walgreen Company
Application part343
Marketing category OTC MONOGRAPH NOT FINAL
Marketing start 2002-04-29
Marketing end 0000-00-00
Substance ACETAMINOPHEN; CAFFEINE; PYRILAMINE MALEATE
Active strength 500 mg/1; mg/1; mg/1
Pharmacologic classes Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 12 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 557ba5c1ecfa…9c80585c8c6e…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0363-0252-10 Menstrual ReliefMaximum Strength 40 in 1 BOTTLE, PLASTIC TABLET, FILM COATED 40 16 0363-0252-10 Menstrual ReliefMaximum Strength 1 in 1 CARTON TABLET, FILM COATED 1 16 0363-0252-21 Menstrual ReliefMaximum Strength 8 in 1 BLISTER PACK TABLET, FILM COATED 8 16 0363-0252-21 Menstrual ReliefMaximum Strength 2 in 1 CARTON TABLET, FILM COATED 2 16
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded ACETAMINOPHEN ACTIVE INGREDIENT 362O9ITL9D MENSTRUAL RELIEF MAXIMUM STRENGTH (ACETAMINOPHEN, CAFFEINE AND PYRILAMINE MALEATE) TABLET [WALGREEN CO.] 3 CAFFEINE ACTIVE INGREDIENT 3G6A5W338E MENSTRUAL RELIEF MAXIMUM STRENGTH (ACETAMINOPHEN, CAFFEINE AND PYRILAMINE MALEATE) TABLET [WALGREEN CO.] 3 PYRILAMINE MALEATE ACTIVE INGREDIENT R35D29L3ZA MENSTRUAL RELIEF MAXIMUM STRENGTH (ACETAMINOPHEN, CAFFEINE AND PYRILAMINE MALEATE) TABLET [WALGREEN CO.] 3 ACETAMINOPHEN ACTIVE MOIETY 362O9ITL9D MENSTRUAL RELIEF MAXIMUM STRENGTH (ACETAMINOPHEN, CAFFEINE AND PYRILAMINE MALEATE) TABLET [WALGREEN CO.] 3 CAFFEINE ACTIVE MOIETY 3G6A5W338E MENSTRUAL RELIEF MAXIMUM STRENGTH (ACETAMINOPHEN, CAFFEINE AND PYRILAMINE MALEATE) TABLET [WALGREEN CO.] 3 PYRILAMINE ACTIVE MOIETY HPE317O9TL MENSTRUAL RELIEF MAXIMUM STRENGTH (ACETAMINOPHEN, CAFFEINE AND PYRILAMINE MALEATE) TABLET [WALGREEN CO.] 3 CROSCARMELLOSE SODIUM INACTIVE INGREDIENT M28OL1HH48 MENSTRUAL RELIEF MAXIMUM STRENGTH (ACETAMINOPHEN, CAFFEINE AND PYRILAMINE MALEATE) TABLET [WALGREEN CO.] 3 HYPROMELLOSES INACTIVE INGREDIENT 3NXW29V3WO MENSTRUAL RELIEF MAXIMUM STRENGTH (ACETAMINOPHEN, CAFFEINE AND PYRILAMINE MALEATE) TABLET [WALGREEN CO.] 3 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 MENSTRUAL RELIEF MAXIMUM STRENGTH (ACETAMINOPHEN, CAFFEINE AND PYRILAMINE MALEATE) TABLET [WALGREEN CO.] 3 POLYDEXTROSE INACTIVE INGREDIENT VH2XOU12IE MENSTRUAL RELIEF MAXIMUM STRENGTH (ACETAMINOPHEN, CAFFEINE AND PYRILAMINE MALEATE) TABLET [WALGREEN CO.] 3 POLYETHYLENE GLYCOLS INACTIVE INGREDIENT 3WJQ0SDW1A MENSTRUAL RELIEF MAXIMUM STRENGTH (ACETAMINOPHEN, CAFFEINE AND PYRILAMINE MALEATE) TABLET [WALGREEN CO.] 3 STEARIC ACID INACTIVE INGREDIENT 4ELV7Z65AP MENSTRUAL RELIEF MAXIMUM STRENGTH (ACETAMINOPHEN, CAFFEINE AND PYRILAMINE MALEATE) TABLET [WALGREEN CO.] 3 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP MENSTRUAL RELIEF MAXIMUM STRENGTH (ACETAMINOPHEN, CAFFEINE AND PYRILAMINE MALEATE) TABLET [WALGREEN CO.] 3 TRIACETIN INACTIVE INGREDIENT XHX3C3X673 MENSTRUAL RELIEF MAXIMUM STRENGTH (ACETAMINOPHEN, CAFFEINE AND PYRILAMINE MALEATE) TABLET [WALGREEN CO.] 3
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0363-0252 MENSTRUAL RELIEF MAXIMUM STRENGTH (ACETAMINOPHEN, CAFFEINE AND PYRILAMINE MALEATE) TABLET, FILM COATED [WALGREEN COMPANY] 16 Legacy NDC, 4 package rows 20250131_50b0c3b6-c4d1-4f00-a006-05d0647fa0f6.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 0363-0252-10 00363025210 1 BOTTLE, PLASTIC in 1 CARTON (0363-0252-10) > 40 TABLET in 1 BOTTLE, PLASTIC 2002-04-29 0000-00-00 No No Current 0363-0252-21 00363025221 2 BLISTER PACK in 1 CARTON (0363-0252-21) > 8 TABLET in 1 BLISTER PACK 2 blister pack 2002-04-29 0000-00-00 No No Current